Category: DTC Advertising

DTC Advertising

DTC Advertising

Major Health Advertisers Inadvertently Placing Ads on Misinformation Sites

Major Health Advertisers Inadvertently Placing Ads on Misinformation Sites

March 8, 2021 – Pharmaceutical companies and other healthcare stakeholders who utilize programmatic advertising are unintentionally placing ads that promote COVID-19 vaccines, vaccine distribution and safe pandemic practices on websites that are spreading false health information, according to a recent report from Newsguard. “Throughout the pandemic, many of the world’s largest and most trusted brands […]

Read more

DTC Advertising

OPDP Cites Xeris for Risk Presentation Issues in DTC TV Ad

OPDP Cites Xeris for Risk Presentation Issues in DTC TV Ad

Sept. 7, 2020 – A direct-to-consumer (DTC) television ad featuring an animated syringe yielded Xeris Pharmaceuticals Inc. an enforcement letter from the FDA’s Office of Prescription Drug Promotion (OPDP) for alleged violations related to the product’s risk profile that “create a misleading impression about its safety and effectiveness.” In an Aug. 14 Untitled Letter, OPDP […]

Read more

DTC Advertising

Citizen Petition Says Music in DTC Ads Distracts from Risk Info, Calls for FDA Ban

Citizen Petition Says Music in DTC Ads Distracts from Risk Info, Calls for FDA Ban

Aug. 3, 2020 – The background music in direct-to-consumer (DTC) ads “is a distraction from the presentation of risks … and bombards the viewer with excess stimuli making it difficult for them to retain the information,” according to an Aug. 3 Citizen Petition sent to the Food and Drug Administration (FDA) by Knowledge Ecology International […]

Read more

DTC Advertising

Several Pharma Companies Join Facebook Ad Boycott

Several Pharma Companies Join Facebook Ad Boycott

July 6, 2020 – Bayer AG, Merck KGaA, Novartis, Pfizer and Vertex are joining other major advertisers in support of a July Facebook ad boycott (#StopHateForProfit), a campaign started by six civil rights organizations – the Anti-Defamation League, NAACP, Sleeping Giants, Color Of Change, Free Press and Common Sense – that calls on corporate advertisers to […]

Read more

DTC Advertising

New Harris Poll Shows Pharma Industry Reputation Is Improving During COVID-19

New Harris Poll Shows Pharma Industry Reputation Is Improving During COVID-19

June 1, 2020 – Although the pharmaceutical industry’s reputation has taken a hit in recent years over drug-pricing concerns, the results of recent Harris Polls show that the industry’s role in helping to combat COVID-19 may be helping to rehabilitate its image. According to Harris Polls conducted between March 14 and May 17, 33 percent […]

Read more

DTC Advertising

Appeals Court Questions CMS Rule for DTC Ad List Prices

Appeals Court Questions CMS Rule for DTC Ad List Prices

Jan. 20, 2020 — A three-judge panel in the U.S. Court of Appeals for the District of Columbia sounded skeptical of the Trump administration’s position when it heard oral arguments last week in the government’s appeal of a U.S. District Court judge’s decision that struck down a Centers for Medicare & Medicaid Services (CMS) rule […]

Read more

DTC Advertising

OPDP Study of Oncology DTC TV Ads Needs Tweaking, Commenters Say

OPDP Study of Oncology DTC TV Ads Needs Tweaking, Commenters Say

Dec. 9, 2019 – The Office of Prescription Drug Promotion’s (OPDP’s) proposed study of  the increasingly-common direct-to-consumer (DTC) television advertising for oncology drugs seeks to examine how consumers parse the information they are receiving, but commenters on the proposal argue that some of the study’s parameters should be changed before moving forward. The proposed OPDP […]

Read more

DTC Advertising

DTC Ad Drug Price Rule: Why Did HHS Choose the Wrong Regulations to Amend?

DTC Ad Drug Price Rule: Why Did HHS Choose the Wrong Regulations to Amend?

Oct. 21, 2019 — What is next in the effort to require inclusion of list prices in direct-to-consumer (DTC) promotion of pharmaceuticals? A variety of scenarios were outlined by James Czaban, chair of the FDA Practice Group at DLA Piper in Washington, during a panel at last week’s Food and Drug Law Institute conference on […]

Read more

DTC Advertising

OPDP DTC Research Studies Await Peer Review, Are Poised for Publication

OPDP DTC Research Studies Await Peer Review, Are Poised for Publication

Sept. 16, 2019 – Five research studies conducted by the FDA’s Office of Prescription Drug Promotion (OPDP) – four of which examine aspects of direct-to-consumer (DTC) advertising – are complete and awaiting peer review and publication, according to OPDP’s Website. “Taken together, the OPDP studies now nearing release will make an important contribution to the […]

Read more

Courts/First Amendment

HHS Appealing Federal Court Ruling that Set Aside Drug Prices in TV Ads Rule

HHS Appealing Federal Court Ruling that Set Aside Drug Prices in TV Ads Rule

Aug. 26, 2019 — The Department of Health and Human Services (HHS) last week filed a notice in the U.S. District Court for the District of Columbia stating that it would appeal the July 8 decision of U.S. District Court Judge Amit P. Mehta that declared invalid and set aside the Centers for Medicare & […]

Read more